Related Experiment Video
Updated: Jan 19, 2026

Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video
Published on: June 6, 2020
Pancreatic Intraductal Papillary Mucinous Neoplasm With Elevated Pre-Operative Cystic Carcinoembryonic Antigen Level:
Cameron Beech1, Mollie Freedman-Weiss2, Ronald Salem2
1Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
Carcinoembryonic antigen (CEA) levels in cystic fluid do not reliably predict invasive carcinoma in intraductal papillary mucinous neoplasms (IPMNs). This suggests limited use of CEA for assessing malignancy risk in IPMN patients.
Area of Science:
- Gastroenterology
- Surgical Pathology
- Oncology
Background:
- Intraductal papillary mucinous neoplasms (IPMNs) are cystic pancreatic tumors with malignant potential.
- Accurate assessment of malignancy risk in IPMNs is crucial for patient management.
Purpose of the Study:
- To investigate the correlation between cystic carcinoembryonic antigen (CEA) levels and IPMN subtypes.
- To determine the relationship between CEA levels and the presence of invasive carcinoma in IPMNs.
Main Methods:
- Analysis of cystic fluid CEA levels and pathological variables from 45 IPMN cases.
- Variables included IPMN subtype, lesion size, dysplasia grade, and invasive carcinoma presence.
Main Results:
- A significant correlation was found between pre-operative cystic fluid CEA levels and luminal CEA staining intensity.
- No correlation was observed between CEA levels and mucinous secretions, cytoplasmic CEA staining, mucin glycoprotein expression, lesion size, or dysplasia grade.
- CEA levels demonstrated neither sensitivity nor specificity for detecting invasive carcinoma.
Conclusions:
- Cystic CEA level is not a dependable indicator for the presence or absence of invasive carcinoma in IPMNs.
- The utility of CEA levels in assessing malignancy risk for IPMNs appears limited.
More Related Videos
Related Concept Videos
10:04Laparoscopic Radical Left Pancreatectomy for Pancreatic Cancer: Surgical Strategy and Technique Video
03:34Laparoscopic Duodenum-Preserving Pancreatic Head Resection via Inferior Infracolic Approach: A Surgical Approach for Benign Lesions
02:20Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors
06:30Intraductal Delivery to the Rabbit Mammary Gland
09:32Management of the Uncinate Process in No-Touch Laparoscopic Pancreaticoduodenectomy
09:00A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

